Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2012
11/13/2012US8309074 Use of a fermented milk containing L. casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
11/13/2012CA2549717C Compositions and methods for treating diabetes
11/13/2012CA2534314C Benzothiazole derivatives for the treatment of diabetes
11/13/2012CA2511925C Heterocyclic inhibitors of phosphatases, compositions and uses thereof
11/08/2012WO2012151541A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151523A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012WO2012151346A1 Expression signatures of genes and gene networks associated with skin aging
11/08/2012WO2012150707A1 Low molecular weight compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using low molecular weight compound
11/08/2012WO2012150412A1 Novel combination of 4-(3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy)benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing same
11/08/2012WO2011128628A3 Gelled oral pharmaceutical compositions
11/08/2012US20120284005 System and methods for optimized drug delivery and progression of diseased and normal cells
11/08/2012US20120283285 Treatment of solid tumors with rapamycin derivatives
11/08/2012US20120283206 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282359 Compositions, Kits, and Methods for the Treatment of Conditions Associated with Elevated Cholesterol Levels
11/08/2012US20120282307 Gastric retained gabapentin dosage form
11/08/2012US20120282277 Method for Treating Arteriosclerosis
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2834696A1 Csf-1r inhibitors for treatment of brain tumors
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520311A2 Method of treating hemolytic disease
11/07/2012EP2520302A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
11/07/2012EP2520301A2 Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome
11/07/2012EP2520296A1 New association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
11/07/2012EP2520291A1 Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
11/07/2012EP2519519A2 Substituted naphthalenyl-pyrimidine compounds
11/07/2012EP2519240A2 Pharmaceutical composition comprising metformin and rosuvastatin
11/07/2012EP2519233A1 Pharmaceutical composition for treating alcohol dependency
11/07/2012EP2519231A2 Treatment of disease with proteasome inhibitors background of the invention
11/07/2012EP2519230A2 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
11/07/2012EP2519229A2 New pharmaceutical dosage form for the treatment of gastric acid-related disorders
11/07/2012EP2519115A1 Compositions including pyruvate for companion animals and methods of use thereof
11/07/2012EP2519114A1 Compositions including pyruvate for companion animals and methods of use thereof
11/07/2012CN202516036U Drug carrier
11/07/2012CN1744901B Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
11/07/2012CN102770159A Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
11/07/2012CN102770133A sGC stimulators or sGC activators alone and in combination with PDE5 inhibitors for the treatment of cystic fibrosis
11/07/2012CN102770131A Novel antitumoral use of cabazitaxel
11/07/2012CN102766214A Protein tag-containing SUMO fusion protein and application thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102764440A Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
11/07/2012CN102764439A Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
11/07/2012CN102764438A Novel application of beta3 adrenoceptor agonist
11/07/2012CN102764429A Composition used for increasing regulatory T cells in vivo and use thereof
11/07/2012CN102764244A Solid pharmaceutical dosage form
11/07/2012CN102764242A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
11/07/2012CN102764230A Nasal gel or ointment preparation for preventing and/or treating aspiration allergy
11/07/2012CN102107007B Sterides anti-progestogen composition and preparation method thereof
11/07/2012CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
11/07/2012CN101669941B Method for treating malignant tumors with joint medicament administration and anti-malignant tumor medicament
11/07/2012CN101590051B Drug combination containing nicotinic acid, HMG-CoA reductase inhibitor and alpha-glucosidase inhibitor
11/07/2012CN101563074B Acetaminophen / ibuprofen combinations
11/07/2012CN101415422B Anti-cancer pharmaceutical composition
11/07/2012CN101132693B Compositions and methods for the management of hyperproliferative dermatological conditions
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8304383 Atherosclerosis therapy ; circulation of emulsifiers; using bile salts, saponins or detergent surfactant; concurrent administering with statin
11/06/2012US8304217 Stabilized dihydrolipoic acid and method of producing same
11/06/2012US8303949 Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
11/06/2012CA2412790C Liposomal antineoplastic drugs and uses thereof
11/06/2012CA2365533C Diagnosis and treatment of neuroectodermal tumors
11/01/2012WO2012149535A1 The use of angiotensin ii (at ii) type 1 receptor antagonist in the therapeutic treatment of autism
11/01/2012WO2012149251A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147705A1 Therapeutic agent for inflammatory respiratory diseases comprising trehalose
11/01/2012WO2012147597A1 Camptocormia therapeutic agent
11/01/2012WO2012147518A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012WO2012147056A1 Vaginal composition based on alkyl polyglucosides
11/01/2012WO2012146936A1 Pyrrolnitrin derivatives
11/01/2012WO2012146933A1 Cyprodinil for use in medicine
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277271 Methods and compositions
11/01/2012US20120277235 Compositions For Topical Application Having Androgenic Actions
11/01/2012US20120277221 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/01/2012US20120276220 Method of Treating Hepatitis
11/01/2012US20120276201 Compositions and method for treatment and prophylaxis of inflammatory bowel disease
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276113 Methods of treating and preventing colitis involving il-13 and nk-t cells
11/01/2012CA2834417A1 Novel 3-hydroxyisothiazole 1-oxide derivative
11/01/2012CA2834355A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012CA2833390A1 Hsp90 combination therapy
11/01/2012CA2819632A1 Vaginal composition based on alkyl polyglucosides
10/2012
10/31/2012EP2517728A1 Drug for preventing or treating angiogenic eye diseases
10/31/2012EP2517727A2 Biomarkers for multiple sclerosis and methods of use thereof
10/31/2012EP2517722A2 Treatment of T-cell mediated diseases
10/31/2012EP2517721A2 Treatment of T-cell mediated diseases
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2517710A1 Tamper-resistant oral opioid agonist formulations
10/31/2012EP2517703A1 Carnitine retention
10/31/2012EP2517697A1 Combination composition useful for treating cardiovascular diseases
10/31/2012EP2515917A1 Compositions and methods for eye whitening
10/31/2012EP2515913A2 Use of vitamin d glycosides and sulfates for treatment of disease
10/31/2012EP2515910A1 Use of polysaccharides for treating stress and anxiety
10/31/2012EP2515905A1 Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid
10/31/2012EP2515897A1 A combination for the treatment of osteoarthritis
10/31/2012EP2515894A1 Compositions containing salmeterol, fluticasone and cromoglicic acid
10/31/2012EP2515876A2 Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
10/31/2012EP2515856A2 Aerosol formulation for copd
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 1151